NCT03429387 - PET/CT and Bacterial/Fungal PCR in High Risk Febrile Neutropenia | Biotech Hunter

Enrollment

147

Participants

Timeline

Start Date

January 8, 2018

Primary Completion Date

August 1, 2020

Study Completion Date

January 23, 2021

Conditions

Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaHaematopoietic Stem Cell Transplant, AutologousHaematopoietic Stem Cell Transplant, AllogeneicFebrile Neutropenia

Interventions

DIAGNOSTIC_TEST

FDG-PET/CT

FDG-PET performed with low dose CT

DIAGNOSTIC_TEST

Conventional CT

HRCT and CT of sinuses +/- other regions as per clinician's discretion

Trial Locations (2)

3000

Peter MacCallum Cancer Centre, Melbourne

3052

Melbourne Health, Parkville